Your browser doesn't support javascript.
loading
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
Bowrin, Kevin; Briere, Jean-Baptiste; Fauchier, Laurent; Coleman, Craig; Millier, Aurélie; Toumi, Mondher; Clay, Emilie; Levy, Pierre.
Affiliation
  • Bowrin K; Bayer Plc, Reading, England, United Kingdom.
  • Briere JB; Bayer AG, Berlin, Germany.
  • Fauchier L; Cardiologie, Centre Hospitalier Universitaire Trousseau et Université François Rabelais, Tours, France.
  • Coleman C; University of Connecticut, School of Pharmacy, Storrs, Connecticut, United States of America.
  • Millier A; Creativ-Ceutical, Paris, France.
  • Toumi M; Aix-Marseille University, Marseille, France.
  • Clay E; Creativ-Ceutical, Paris, France.
  • Levy P; Université Paris-Dauphine, PSL Research University, LEDa-LEGOS, Paris, France.
PLoS One ; 15(1): e0225301, 2020.
Article in En | MEDLINE | ID: mdl-31978044
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Atrial Fibrillation / Vitamin K / Stroke / Rivaroxaban Type of study: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2020 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Atrial Fibrillation / Vitamin K / Stroke / Rivaroxaban Type of study: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2020 Type: Article Affiliation country: United kingdom